SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-111210
Filing Date
2022-04-20
Accepted
2022-04-20 16:48:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d292472ddefa14a.htm DEFA14A 12706
2 GRAPHIC g292472g01p01.jpg GRAPHIC 476146
3 GRAPHIC g292472g01p02.jpg GRAPHIC 380206
  Complete submission text file 0001193125-22-111210.txt   1193246
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36644 | Film No.: 22838673
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences